These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34406703)

  • 1. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
    Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
    Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
    Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation.
    Zhou B; Xu M; Lu S; Liu Y; Qi L; Liu T; Tian H; Chen J; Wu D; Xu Y
    Transplant Cell Ther; 2022 Mar; 28(3):173.e1-173.e6. PubMed ID: 34954150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of monitoring E2A- PBX1 fusion gene expression in patients with allogeneic hematopoietic stem cell transplantation].
    Zhao X; Qin Y; Zhang Y; Xu Y; Wang Y; Chen H; Wang F; Wang J; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):989-93. PubMed ID: 26759098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases.
    Zhang J; Yang F; Qiu HY; Wu Q; Kong DQ; Zhou J; Han Y; Wu DP
    Leuk Lymphoma; 2019 Jun; 60(6):1454-1461. PubMed ID: 30714847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
    Gao C; Li ZG; Zhao W; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission.
    Yan CH; Jiang Q; Wang J; Xu LP; Liu DH; Jiang H; Chen H; Zhang XH; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1314-21. PubMed ID: 24747334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Real-time quantitative detection of E2A-PBX1 fusion gene in children with acute lymphoblastic leukemia and its clinical application in minimal residual disease monitoring].
    Zhang R; Liao J; Li G; Sun HQ; Shi YJ; Yang JY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):440-3. PubMed ID: 23791058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
    Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
    J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Philadelphia Chromosome Karyotype and Allogeneic Hematopoietic Stem Cell Transplantation on Patients with Acute Lymphoblastic Leukemia].
    Wang Y; Xu XM; Zhang M; Wang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1397-1406. PubMed ID: 36208241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
    Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
    Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of childhood acute lymphoblastic leukemia with TCF3::PBX1 in CCCG-ALL-2015: A multicenter study.
    Zhang H; Wan Y; Wang H; Cai J; Yu J; Hu S; Fang Y; Gao J; Jiang H; Yang M; Liang C; Jin R; Tian X; Ju X; Hu Q; Jiang H; Li Z; Wang N; Sun L; Leung AWK; Wu X; Qian X; Qian M; Li CK; Yang J; Tang J; Zhu X; Shen S; Zhang L; Pui CH; Zhai X
    Cancer; 2023 Jun; 129(11):1691-1703. PubMed ID: 36943767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
    Bai L; Cheng YF; Lu AD; Suo P; Wang Y; Zuo YX; Yan CH; Wu J; Jia YP; Sun YQ; Chen YH; Chen H; Liu KY; Han W; Xu LP; Wang JB; Tang XF; Chen HR; Zhang LP; Huang XJ
    Leuk Res; 2020 Apr; 91():106333. PubMed ID: 32109757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia.
    Yang M; Tang Y; Zhu P; Lu H; Wan X; Guo Q; Xiao L; Liu C; Guo L; Liu W; Yang Y
    Ann Hematol; 2024 Sep; 103(9):3385-3398. PubMed ID: 38148344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
    Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study.
    Vey N; Thomas X; Picard C; Kovascovicz T; Charin C; Cayuela JM; Dombret H; Dastugue N; Huguet F; Bastard C; Stamatoulas A; Giollant M; Tournilhac O; Macintyre E; Buzyn A; Bories D; Kuentz M; Dreyfus F; Delannoy A; Raynaud S; Gratecos N; Bordessoule D; de Botton S; Preudhomme C; Reman O; Troussard X; Pigneux A; Bilhou C; Vernant JP; Boucheix C; Gabert J;
    Leukemia; 2006 Dec; 20(12):2155-61. PubMed ID: 17039234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Features and Therapeutic Efficacy in Adult Acute Lymphoblastic Leukemia with t (1; 19) (E2A-PBX1)].
    Liu KQ; Gong XY; Zhao XL; Wei H; Wang Y; Lin D; Zhou CL; Liu BC; Wang HJ; Li CW; Li QH; Gong BF; Li Y; Liu YT; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):637-640. PubMed ID: 31204910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.